Log In
BCIQ
Print this Print this
 

LY2608204

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionGlucokinase activator
Molecular Target Glucokinase (GCK) (GK)
Mechanism of ActionGlucokinase activator
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat diabetes
Regulatory Designation
PartnerYabao Pharmaceutical Group Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/07/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today